Zydus Lifesciences Rifaximin Tablets bags USFDA tentative nod for irritable bowel syndrome with diarrhoea Written By Ruchika Sharma2 Jun 2025 12:58 PM ISTAhmedabad: Pharma major, Zydus Lifesciences Limited, has received tentative approval from the United States Food and Drug...
USFDA successfully completes inspection at Piramal Pharma Canada facility Written By Ruchika Sharma2 Jun 2025 12:00 PM ISTMumbai: Piramal Pharma Limited has announced that the US Food and Drug Administration (USFDA) has successfully completed inspection...
Cipla (EU), UK incorporates new wholly owned subsidiary in Germany Ruchika Sharma1 Jun 2025 5:48 PM ISTMumbai: Cipla has announced that Cipla (EU) Limited, UK, a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary...
Illegally marketed formulations under name of Biovus Pharma seized at Moosarambagh Ruchika Sharma1 Jun 2025 5:00 PM ISTTelangana: Drugs Control Administration, Telangana has seized illegally marketed formulations under the name of Biovus Pharma, without a drug...
Fresenius Told To Submit Approval Basis, Phase III Data for Calcium Chloride Dihydrate Infusion Proposal Written By Dr. Divya Colin1 Jun 2025 4:30 PM ISTNew Delhi: In response to the proposal presented by Fresenius Medical Care, the Subject Expert Committee (SEC) functional under the Central Drug...
CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III Trial Written By Dr. Divya Colin1 Jun 2025 4:00 PM ISTNew Delhi: Reviewing the Phase III clinical of the Ianalumab (VAY736) presented by Novartis, the Subject Expert Committee (SEC) functional under the...
Itepekimab met primary endpoint in one of two COPD phase 3 studies: Sanofi, Regeneron Written By Ruchika Sharma1 Jun 2025 3:00 PM ISTParis: Sanofi has announced that the AERIFY-1 phase 3 study evaluating itepekimab in former smokers with inadequately controlled chronic...
Strides Pharma Science: Senior Vice President - Treasury Ramesh RJ supperannuates Ruchika Sharma1 Jun 2025 2:30 PM ISTMumbai: Strides Pharma Science Limited has announced that Ramesh RJ, Senior Vice President - Treasury, one of the Senior Management...
Delhi HC Restrains Dr Reddy's from Selling Semaglutide Drug in India Amid Novo Nordisk Row Ruchika Sharma31 May 2025 6:19 PM ISTNovo Nordisk has accused Dr Reddy's and OneSource of importing semaglutide API and using it to make and export formulations.
Justify Sample Size Hike in FDC Trial of Zibotentan-Dapagliflozin, CDSCO Panel Tells AstraZeneca Written By Dr. Divya Colin31 May 2025 6:04 PM ISTNew Delhi: Reviewing the amendment protocol of the AstraZeneca's fixed dose combination (FDC) Zibotentan plus Dapagliflozin, the Subject Expert...
Bayer Gets CDSCO Panel Nod To Conduct Phase 3 Trial for Finerenone Written By Dr. Divya Colin31 May 2025 5:56 PM ISTNew Delhi: Bayer Pharmaceutical has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Merck, Daiichi Sankyo withdraw US appication for patritumab deruxtecan for advanced or metastatic EGFR-mutated non-small cell lung cancer Written By Ruchika Sharma31 May 2025 3:18 PM ISTRahway: Daiichi Sankyo and Merck, known as MSD outside of the United States and Canada, have announced that the Biologics License Application...
